Daewoong Pharmaceutical Co., Ltd (KOSE: A069620)
Health Care · Pharmaceuticals · KR
₩119,500.00
-4.09% today · -10.8% 1Y
Daewoong Pharmaceutical Co., Ltd (KOSE: A069620) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $992.14M.
Over the last twelve months the share price has lost 10.8%, trading between 105.00K and 199.40K.
Tweenvest scores Daewoong Pharmaceutical Co., Ltd across four factors: quality 70/100, value 79/100, growth 74/100, dividend 9/100. Its strongest factor is value.
A069620 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $992.14M
- Revenue (TTM)
- $1.06B
- P/E
- 7.03
- EPS
- 16,988.81
- Dividend yield
- 0.50%
- Beta (5Y)
- 0.01
- 52-week high
- ₩199,400.00
- 52-week low
- ₩105,000.00
- Avg volume (3M)
- —
- Shares outstanding
- 11.51M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.